| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |